AIG
DNLI icon

American International Group’s Denali Therapeutics DNLI Stock Holding History

American International Group’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-58,847
Closed -$1.21M – 765
2024
Q1 		$1.21M Buy
58,847
+122
+0.2% +$2.29K ﹤0.01% 1206
2023
Q4 		$1.26M Sell
58,725
-237
-0.4% -$4.69K 0.01% 1186
2023
Q3 		$1.22M Buy
58,962
+2,096
+4% +$53.2K 0.01% 1147
2023
Q2 		$1.68M Buy
56,866
+4,336
+8% +$122K 0.01% 1018
2023
Q1 		$1.21M Buy
52,530
+1,046
+2% +$28.8K 0.01% 1145
2022
Q4 		$1.43M Buy
51,484
+4,707
+10% +$140K 0.01% 1049
2022
Q3 		$1.44M Buy
46,777
+661
+1% +$21.5K 0.01% 1037
2022
Q2 		$1.36M Buy
46,116
+945
+2% +$24.8K 0.01% 1077
2022
Q1 		$1.45M Sell
45,171
-3,179
-7% -$109K 0.01% 1143
2021
Q4 		$2.16M Sell
48,350
-1,447
-3% -$68.6K 0.01% 1044
2021
Q3 		$2.51M Sell
49,797
-1,183
-2% -$66.7K 0.01% 965
2021
Q2 		$4M Buy
50,980
+12,457
+32% +$771K 0.01% 897
2021
Q1 		$2.2M Sell
38,523
-151
-0.4% -$10.1K 0.01% 1072
2020
Q4 		$3.24M Buy
38,674
+1,071
+3% +$64.7K 0.01% 920
2020
Q3 		$1.35M Sell
37,603
-856
-2% -$25.8K 0.01% 1111
2020
Q2 		$930K Buy
38,459
+7,594
+25% +$179K ﹤0.01% 1263
2020
Q1 		$540K Buy
30,865
+840
+3% +$17.5K ﹤0.01% 1385
2019
Q4 		$523K Sell
30,025
-252
-0.8% -$4.2K ﹤0.01% 1668
2019
Q3 		$464K Sell
30,277
-211
-0.7% -$4.03K ﹤0.01% 1705
2019
Q2 		$633K Buy
30,488
+1,430
+5% +$32K ﹤0.01% 1570
2019
Q1 		$675K Sell
29,058
-942
-3% -$19.7K ﹤0.01% 1543
2018
Q4 		$620K Sell
30,000
-231
-0.8% -$4.19K ﹤0.01% 1547
2018
Q3 		$657K Buy
30,231
+19,217
+174% +$318K ﹤0.01% 1711
2018
Q2 		$168K Buy
11,014
+697
+7% +$13.1K ﹤0.01% 2465
2018
Q1 		$203K Buy
+10,317
New +$212K ﹤0.01% 2253

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

American International Group's DNLI Position: Q2 2024 in Review

American International Group sold out of Denali Therapeutics (DNLI) in Q2 2024, closing a stake of 58,847 shares — an estimated $1.21M sold.

American International Group first reported a position in DNLI in Q1 2018 and held it in 25 quarters. The position peaked at $4M in Q2 2021. 203 funds tracked by Wall St. Rank hold DNLI as of Q2 2024.

  • American International Group reported no remaining Denali Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 58,847 Denali Therapeutics shares in Q2 2024, an estimated $1.21M.
  • American International Group first reported a position in Denali Therapeutics in Q1 2018 and held it in 25 quarters.
  • American International Group's Denali Therapeutics position peaked at $4M in Q2 2021.
  • 203 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.